// App-Quantinova.ai

1986 : The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Over Chemotherapy As Post-Remission Treatment for Patients with High-Risk Acute Lymphoblastic Leukemia in First Remission

Researchers

Presenter

  • han-Bo Dou

Principal Investigators

  • Ling Wang

  • Wei Tang

Medical Centers

  • RUI JIN hospital, shanghai, China

  • Rheumatology, Renji Hospital, Shanghai, China

  • Hematology, Shanghai Institute of Hematology, RuiJin Hospital, Shanghai, China,

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

  • White Blood Cell

Drug/Treatment

  • Busulfan

  • Allopurinol

Outcome

  • N/A

Study Design

  • randomized

  • superiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved